Genzyme, International Chemical Investors Group deal

International Chemical will acquire Genzyme's pharmaceutical intermediates business, excluding the drug delivery technologies portion, for an undisclosed

Read the full 176 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE